© 2000 by Oxford University Press
Journal of the National Cancer Institute, Vol. 92, No. 9, 680-681,
May 3, 2000
© 2000 Oxford University Press
NEWS |
HPV in Oropharyngeal Cancers: New Data Inspire Hope for Vaccines
The hunt for human papillomavirus in head and neck cancer is getting close enough to its quarry to inspire visions of clinical benefit.
At Johns Hopkins Oncology Center, where Maura Gillison, M.D., and colleagues report finding a likely causal association between HPV and oropharyngeal cancers (see p. 709), plans are under way to test HPV treatment vaccines in patients with these tumors. The trial could begin in about a year, said Johns Hopkins immunologist Drew Pardol, M.D.
Several HPV treatment vaccines are in trials for cervical cancer around the world, but this is likely to be the first in head and neck patients.
Fueling hope for the vaccines are indications in the
Trials Planned
International Data
![]()
CiteULike
Connotea
Del.icio.us What's this?
This article has been cited by other articles:
![]() |
S. Begum, M. L. Gillison, T. L. Nicol, and W. H. Westra Detection of Human Papillomavirus-16 in Fine-Needle Aspirates to Determine Tumor Origin in Patients with Metastatic Squamous Cell Carcinoma of the Head and Neck Clin. Cancer Res., February 15, 2007; 13(4): 1186 - 1191. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Begum, M. L. Gillison, M. A. Ansari-Lari, K. Shah, and W. H. Westra Detection of Human Papillomavirus in Cervical Lymph Nodes: A Highly Effective Strategy for Localizing Site of Tumor Origin Clin. Cancer Res., December 15, 2003; 9(17): 6469 - 6475. [Abstract] [Full Text] [PDF] |
||||
